Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OCULAR THERAPEUTIX, INC Director's Dealing 2014

Jul 25, 2014

31615_dirs_2014-07-24_9d52646f-b13a-40a2-864e-e91e8eee7a0a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OCULAR THERAPEUTIX, INC (OCUL)
CIK: 0001393434
Period of Report: 2014-07-24

Reporting Person: GARVEY JAMES M (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $8.80 2024-04-13 Common Stock (11363) Direct

Footnotes

F1: This option was granted on April 14, 2014 and vests over three years, vesting 2.778% monthly beginning on the one month anniversary of the Issuer's initial public offering.